Publications by authors named "Voravit Ratanatharathorn"

Claim this Profile
H
Haploidentical vs. mismatched unrelated donor transplants with posttransplant cyclophosphamide-based GVHD prophylaxis.
Dipenkumar Modi, Seongho Kim, Maya Shatta, Abhinav Deol, Andrew Kin, Voravit Ratanatharathorn

Bone Marrow Transplant· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem cell transplant outcomes between TBI-containing reduced intensity and myeloablative conditioning regimens for ALL in complete remission.
Dipenkumar Modi, Samer Alkassis, Seongho Kim, Andrew Kin, Abhinav Deol, Voravit Ratanatharathorn

Leuk Lymphoma· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement.
Rohtesh S Mehta, Haris Ali, Yang Dai, Bert Yao, Bethany Overman, Voravit Ratanatharathorn

Bone Marrow Transplant· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial.
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, Brent R Logan, Farhad Khimani, Voravit Ratanatharathorn

Transplant Cell Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Pre-transplant Induction Therapy on Outcomes of Patients Who Undergo Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in First Complete Remission.
Omar Albanyan, Samer Alkassis, Seongho Kim, Andrew Kin, Asif Alavi, Voravit Ratanatharathorn

Hematol Oncol Stem Cell Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of High-Dose Adjuvant Chemotherapy Followed by Autologous Stem Cell Transplantation in Locally Advanced Triple-Negative Breast Cancer: A Retrospective Chart Review.
Bayan Al-Share, Hadeel Assad, Judith Abrams, Abhinav Deol, Asif Alavi, Voravit Ratanatharathorn

J Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents.
Harsh Shah, Hyejeong Jang, Paramveer Singh, Jorgena Kosti, Andrew Kin, Voravit Ratanatharathorn

Leuk Lymphoma· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplant Cyclophosphamide Versus Thymoglobulin in HLA-Mismatched Unrelated Donor Transplant for Acute Myelogenous Leukemia and Myelodysplastic Syndrome.
Dipenkumar Modi, Kyle Kondrat, Seongho Kim, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn

Transplant Cell Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Grade 3-4 cytokine release syndrome is associated with poor survival in haploidentical peripheral blood stem cell transplantation.
Dipenkumar Modi, Omar Albanyan, Seongho Kim, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn

Leuk Lymphoma· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Fludarabine, Melphalan and Total Body Irradiation as a Reduced Intensity Conditioning Regimen in Matched Donor Allogeneic Peripheral Blood Stem Cell Transplantation.
Dipenkumar Modi, Jie Chi, Seongho Kim, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn

Transplant Cell Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide.
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, Brent R Logan, Farhad Khimani, Voravit Ratanatharathorn

J Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of myeloablative and reduced intensity conditioning unrelated donor allogeneic peripheral blood stem cell transplant outcomes for AML using thymoglobulin for GVHD prophylaxis.
Dipenkumar Modi, Vijendra Singh, Seongho Kim, Lois Ayash, Abhinav Deol, Voravit Ratanatharathorn

Ann Hematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation.
Dipenkumar Modi, Seongho Kim, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn

Bone Marrow Transplant· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G-CSF use post peripheral blood stem cell transplant is associated with faster neutrophil engraftment, shorter hospital stay and increased incidence of chronic GVHD.
Vijendra Singh, Hyejeong Jang, Seongho Kim, Lois Ayash, Asif Alavi, Voravit Ratanatharathorn

Leuk Lymphoma· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute lymphocyte count on the first day of thymoglobulin predicts relapse-free survival in matched unrelated peripheral blood stem cell transplantation.
Dipenkumar Modi, Seongho Kim, Malini Surapaneni, Lois Ayash, Voravit Ratanatharathorn

Leuk Lymphoma· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?
Nadine Abdallah, Seongho Kim, Lois Ayash, Scott Klimecki, Marie Ventimiglia, Voravit Ratanatharathorn

Bone Marrow Transplant· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide maintenance after second autologous stem cell transplant improves overall survival in multiple myeloma.
Dipenkumar Modi, Jie Chi, Seongho Kim, Lois Ayash, Asif Alavi, Voravit Ratanatharathorn

Leuk Lymphoma· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R-BEAM versus Reduced-Intensity Conditioning Regimens in Patients Undergoing Allogeneic Stem Cell Transplantation for Relapsed Refractory Diffuse Large B Cell Lymphoma.
Dipenkumar Modi, Seongho Kim, Malini Surapaneni, Lois Ayash, Asif Alavi, Voravit Ratanatharathorn

Biol Blood Marrow Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilized grafts.
Harsh Shah, Seongho Kim, Paramveer Singh, Asif Alavi, Voravit Ratanatharathorn

Am J Hematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-transplant hypomethylating agents do not influence post-transplant survival in myelodysplastic syndrome.
Dipenkumar Modi, Seongho Kim, Vijendra Singh, Lois Ayash, Asif Alavi, Voravit Ratanatharathorn

Leuk Lymphoma· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Graft-Versus-Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients.
Dipenkumar Modi, Jing Christine Ye, Malini Surapaneni, Vijendra Singh, Wei Chen, Voravit Ratanatharathorn

Am J Hematol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma.
Dipenkumar Modi, Malini Surapaneni, Seongho Kim, Lois Ayash, Asif Alavi, Voravit Ratanatharathorn

Leuk Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation.
Divaya Bhutani, Charles Jaiyeoba, Seongho Kim, Paul Naylor, Joseph P Uberti, Voravit Ratanatharathorn

Bone Marrow Transplant· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation.
Dipenkumar Modi, Zaid Al-Kadhimi, Wei Chen, Hyejeong Jang, Abhinav Deol, Voravit Ratanatharathorn

Am J Hematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune T cells can transfer and boost anti-breast cancer immunity.
Archana Thakur, Ritesh Rathore, Sri Vidya Kondadasula, Joseph P Uberti, Voravit Ratanatharathorn

Oncoimmunology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis